CARMAT
Develops a self-regulating total artificial heart for end-stage heart failure.
ALCAR | PA
Overview
Corporate Details
- ISIN(s):
- FR0010907956
- LEI:
- 969500ARXACM0P0KH333
- Country:
- France
- Address:
- 36 AVENUE DE L'EUROPE, 78140 VELIZY-VILLACOUBLAY
- Website:
- https://www.carmatsa.com/en/
- Sector:
- Manufacturing
Description
CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-09-19 08:00 |
Informations privilégiées / Autres communiqués
|
French | 889.7 KB | ||
| 2019-09-19 08:00 |
Inside Information / Other news releases
|
English | 956.1 KB | ||
| 2019-09-18 18:20 |
Informations privilégiées / Autres communiqués
|
French | 211.0 KB | ||
| 2019-09-18 18:20 |
Inside Information / Other news releases
|
English | 254.7 KB | ||
| 2019-09-18 17:51 |
Inside Information / News release on accounts, results
|
English | 256.7 KB | ||
| 2019-09-18 17:51 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 237.3 KB | ||
| 2019-09-18 17:45 |
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
|
French | 560.4 KB | ||
| 2019-09-12 18:00 |
Informations privilégiées / Autres communiqués
|
French | 202.0 KB | ||
| 2019-09-12 18:00 |
Inside Information / Other news releases
|
English | 219.4 KB | ||
| 2019-08-29 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 91.1 KB | ||
| 2019-08-28 07:00 |
Inside Information / Other news releases
|
English | 208.3 KB | ||
| 2019-08-28 07:00 |
Informations privilégiées / Autres communiqués
|
French | 191.2 KB | ||
| 2019-07-08 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 250.0 KB | ||
| 2019-07-04 19:30 |
Informations privilégiées / Autres communiqués
|
French | 190.6 KB | ||
| 2019-07-04 19:30 |
Inside Information / Other news releases
|
French | 194.6 KB |
Automate Your Workflow. Get a real-time feed of all CARMAT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CARMAT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CARMAT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-29 | N/A | Other | Other | 375,939 | 1,499,996.61 EUR |
| 2024-01-29 | N/A | Other | Other | 62,656 | 249,997.44 EUR |
| 2023-10-23 | N/A | Other | Other | 1,944,442 | 6,999,991.20 EUR |
| 2023-10-23 | N/A | Other | Other | 1,041,666 | 3,749,997.60 EUR |
| 2023-10-23 | N/A | Other | Other | 138,888 | 499,996.80 EUR |
| 2023-10-19 | N/A | Other | Sell | 10,000 | 33,200.00 EUR |
| 2023-10-15 | N/A | Other | Other | 1,041,666 | 3,749,997.60 EUR |
Peer Companies
